Thus, the aims of this study are to study the activation of HO-1 by hemin in humans and its protective effect in post-ERCP acute pancreatitis incidence and to use the human situation of post-ERCP acute pancreatitis as early pancreatitis model to study the administration of hemin as treatment of acute pancreatitis in general. This evidence concerns the gene HMOX1 and pancreatitis.